Case report: Successful outcome of treatment using rituximab in an adult patient with refractory minimal change disease and β-thalassemia complicating autoimmune hemolytic anemia

Minimal change disease (MCD) is one of the common causes of idiopathic nephrotic syndrome (INS), accounting for 10–20% of INS in adults. Glucocorticoids are the most commonly used and effective drugs in the treatment of MCD, but there is still a proportion of adult patients with MCD who are characte...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Jing, Zhao, Zhigang, Zhang, Changrong, Song, Xue, Lu, Chen, Tian, Xuefei, Jiang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669371/
https://www.ncbi.nlm.nih.gov/pubmed/36405580
http://dx.doi.org/10.3389/fmed.2022.1059740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669371/
https://www.ncbi.nlm.nih.gov/pubmed/36405580
http://dx.doi.org/10.3389/fmed.2022.1059740

Ejemplares similares